Tuesday, May 29, 2007
ATLANTIC CITY, New Jersey - A New Jersey jury found that Swiss drugmaker Roche Holding AG failed to adequately warn a patient of the bowel disease risks associated with its acne medicine Accutane and awarded him $2.5 million in damages.
Free Accutane Case EvaluationThe jury, during its third day of deliberations, also found that the failure to warn was a major contributing cause of his contracting the bowel disease and awarded the plaintiff an additional $119,000 to cover medical expenses.
The plaintiff, Andrew McCarrell, a 36-year-old computer manager from Alabama, said he had undergone multiple surgeries, including having his colon removed, after taking the drug in 1995. I'm ecstatic," he told reporters. "I hope this means (other plaintiffs) will finally get some justice. They deserve it just as much as I do.
"Hopefully, this will just be the start of getting them some relief," McCarrell said
Free Case Evaluation
Thank You! Thank you for your recent inquiry. I, or a member of my
staff will contact you by e-mail or telephone to obtain further details.
Send Email Instead Sorry, There was a problem sending your request. Click the button above to send me an email at email@example.com. I, or a member of my staff will contact you by e-mail or telephone to obtain further details of your Accutane ingestion.